Oren Pasvolsky

Peer-Reviewed Articles

1. Yalniz FF, Greenbaum U, Pasvolsky O, Milton DR, Kanagal-Shamanna R, Ramdial J, Srour S, Mehta R, Alousi A, Popat UR, Nieto Y, Kebriaei P, Al-Atrash G, Oran B, Hosing C, Ahmed S, Champlin RE, Shpall EJ, Qazilbash MH, Bashir Q. Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation. Transplant Cell Ther 30(2):205.e1-205.e12, 2024. e-Pub 2023. PMID: 37437764.
2. Pasvolsky O , Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Tewari P, Crawford-Suber L, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Outcomes of young adults (aged Less than or equal to 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant. Br J Haematol 202(4):866-873, 2023. e-Pub 2023. PMID: 37376789.
3. Pasvolsky O , Kebriaei P, Shah BD, Jabbour E, Jain N. Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead. Blood Adv 7(14):3350-3360, 2023. PMID: 36912764.
4. Strati P, Pasvolsky O , Feng L, Xu G, Tewari SO, Varghese J, Ow K, Santiago M, Al Zaki A, Jallouk A, Neelapu SS, Kebriaei P, Shpall EJ, Ahmed S. ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV. Blood Adv 7(11):2586-2589, 2023. PMID: 36745104.
5. Pasvolsky O , Bashir Q. Autologous transplant and second malignancies in MM. Blood Adv 7(12):2731-2732, 2023. PMID: 37318936.
6. Pasvolsky O , Saliba RM, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour S, Saini N, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant. Br J Haematol 201(4):e37-e41, 2023. e-Pub 2023. PMID: 36916461.
7. Pasvolsky O , Milton DR, Rauf M, Ghanem S, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Rezvani K, Champlin R, Shpall EJ, Lin P, Qazilbash MH. Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients. Blood Cancer J 13(1):68, 2023. e-Pub 2023. PMID: 37137874.
8. Pasvolsky O , Gaballa MR, Milton DR, Masood A, Sami SS, Tanner MR, Bashir Q, Srour S, Saini N, Ramdial J, Nieto Y, Tang G, Lin P, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience. Transplant Cell Ther 29(4):260.e1-260.e6, 2023. e-Pub 2023. PMID: 36646323.
9. Yeshurun M, Rozovski U, Shargian L, Pasvolsky O , van der Werf S, Tridello G, Knelange N, Mikulska M, Styczynski J, Averbuch D, de la Camara R. Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey. Bone Marrow Transplant 58(4):414-423, 2023. e-Pub 2023. PMID: 36653669.
10. Shargian L, Amit O, Bernstine H, Gurion R, Gafter-Gvili A, Rozovski U, Pasvolsky O , Perets G, Horowitz NA, Halloun J, Perry C, Avivi I, Raanani P, Yeshurun M, Ram R. The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study. Eur J Haematol 110(2):149-156, 2023. e-Pub 2022. PMID: 36251268.
11. Pasvolsky O , Saliba RM, Ledesma C, Popat UR, Alousi A, Olson A, Oran B, Hosing C, Bashir Q, Qazilbash MH, Short NJ, Ravandi F, Champlin R, Shpall EJ, Kebriaei P. Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. Am J Hematol 98(2):E35-E37, 2023. e-Pub 2022. PMID: 36502492.
12. Nieto Y, Pasvolsky O , Bassett R, Ghanem S, Cuglievan B, Tewari P, Hosing C, Srour S, Ramdial J, Mahadeo K, Khazal S, Petropoulos D, Popat U, Qazilbash M, Kebriaei P, Champlin R, Shpall E. Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant. Res Sq, 2023. e-Pub 2023. PMID: 36798261.
13. Pasvolsky O , Berger T, Geiger KR, Akirov A, Bshara E, Raanani P, Gafter-Gvili A, Shochat T, Rozovski U, Gurion R. Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitus. Leuk Lymphoma 63(14):3378-3384, 2022. e-Pub 2022. PMID: 36067523.
14. Pasvolsky O , Milton DR, Rauf M, Tanner MR, Bashir Q, Srour S, Tang G, Saini N, Ramdial J, Masood A, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma. Transplant Cell Ther 28(11):752.e1-752.e6, 2022. e-Pub 2022. PMID: 35940528.
15. Berger T, Geiger KR, Yeshurun M, Gafter-Gvili A, Shochat T, Gurion R, Raanani P, Pasvolsky O . Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study. Leuk Lymphoma 63(10):2461-2468, 2022. e-Pub 2022. PMID: 35634737.
16. Geiger KR, Pasvolsky O , Berger T, Raanani P, Shochat T, Gurion R, Anati T, Groshar D, Gafter-Gvili A, Bernstine H. Effect of steroid treatment on the diagnostic yield of baseline 18f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma. EJNMMI Res 12(1):59, 2022. e-Pub 2022. PMID: 36104603.
17. Pasvolsky O , Popat UR. Unravelling ALL: The Keys to Improved Post-Transplant Survival in Acute Lymphoblastic Leukemia. Transplant Cell Ther 28(8):415-416, 2022. PMID: 35914901.
18. Gaballa MR, Ma J, Rauf M, Bassett R, Pasvolsky O , Tanner MR, Bashir Q, Srour SA, Saini N, Ramdial J, Nieto Y, Murphy R, Rezvani K, Tang G, Lin P, Lee HC, Patel KK, Ullah MR, Kaufman GP, Manasanch EE, Kebriaei P, Thomas SK, Weber DM, Shpall EJ, Champlin RE, Orlowski RZ, Qazilbash MH. KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma. Bone Marrow Transplant 57(7):1142-1149, 2022. e-Pub 2022. PMID: 35523847.
19. Afrough A, Pasvolsky O , Ma J, Srour S, Bashir Q, Saini N, Hosing C, Popat UR, Kebriaei P, Delgado R, Ullah MR, Murphy R, Manasanch EE, Lee HC, Kaufman GP, Patel KK, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 28(6):307.e1-307.e8, 2022. e-Pub 2022. PMID: 35331973.
20. Pasvolsky O , Shimony S, Ram R, Shimoni A, Shargian L, Avni B, Wolach O, Shochat T, Yerushalmi R, Amit O, Raanani P, Yeshurun M. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study. Ann Hematol 101(2):379-387, 2022. e-Pub 2021. PMID: 34628534.
21. Yeshurun M, Pasvolsky O, Shargian L, Yahav D, Ben-Zvi H, Rubinstein M, Sela-Navon M, Wolach O, Raanani P, Rozovski U. Humoral serological response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation. Clin Microbiol Infect 28(2):303.e1-303.e4, 2022. e-Pub 2021. PMID: 34715348.
22. Zoref-Lorenz A, Murakami J, Hofstetter L, Iyer S, Alotaibi AS, Mohamed SF, Miller PG, Guber E, Weinstein S, Yacobovich J, Nikiforow S, Ebert BL, Lane A, Pasvolsky O, Raanani P, Nagler A, Berliner N, Daver N, Ellis M, Jordan MB. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood 139(7):1098-1110, 2022. PMID: 34780598.
23. Pasvolsky O , Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S, Nagler A, Nishihori T, Parrondo RD, Patel S, Schroeder MA, Usmani SZ, Wang T, Wirk B, Kumar S, Shah N, Qazilbash MH, D'Souza A. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplant 57(1):31-37, 2022. e-Pub 2021. PMID: 34608275.
24. Berger T, Shacham Abulafia A, Shimony S, Pasvolsky O , Vaxman I, Miron Y, Feldman S, Leader A, Raanani P. Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia. Acta Haematol 145(6):619-626, 2022. e-Pub 2022. PMID: 35908535.
25. Vaxman I, Visram A, Pasvolsky O , Kumar S, Dispenzieri A, Buadi F, Dingli D, Lacy M, Hayman S, Kyle R, Kapoor P, Leung N, Gonsalves W, Kourelis T, Warsame R, Gertz M. Retroperitoneal involvement with light chain amyloidosis- case series and literature review. Leuk Lymphoma 62(2):316-322, 2021. e-Pub 2020. PMID: 33118418.
26. Pasvolsky O , Daher M, Alatrash G, Marin D, Daver N, Ravandi F, Rezvani K, Shpall E, Kebriaei P. CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia. Front Oncol 11:800110, 2021. e-Pub 2022. PMID: 35083154.
27. Shargian-Alon L, Wolach O, Rozovski U, Yahav D, Sela-Navon M, Rubinstein M, Oniashvilli N, Pasvolsky O , Raanani P, Yeshurun M. Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia. Ann Hematol 99(12):2939-2945, 2020. e-Pub 2020. PMID: 32892274.
28. Ganzel C, Ram R, Gural A, Wolach O, Gino-Moor S, Vainstein V, Nachmias B, Apel A, Koren-Michowitz M, Pasvolsky O , Yerushalmi R, Danylesko I, Cohen Y, Peretz G, Moshe Y, Zektser M, Yeganeh S, Rowe JM, Ofran Y. Venetoclax is safe and efficacious in relapsed/refractory AML. Leuk Lymphoma 61(9):2221-2225, 2020. e-Pub 2020. PMID: 32420775.
29. Yeshurun M, Rozovski U, Pasvolsky O , Wolach O, Ram R, Amit O, Zuckerman T, Pek A, Rubinstein M, Sela-Navon M, Raanani P, Shargian-Alon L. Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study. Blood Adv 4(16):3822-3828, 2020. PMID: 32790844.
30. Uziel O, Lahav M, Shargian L, Beery E, Pasvolsky O , Rozovski U, Raanani P, Yeshurun M. Premature ageing following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55(7):1438-1446, 2020. e-Pub 2020. PMID: 32094417.
31. Uziel O, Lahav M, Shargian L, Beery E, Pasvolsky O , Rozovski U, Raanani P, Yeshurun M. Correction: Premature ageing following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55(7):1519, 2020. PMID: 32269306.
32. Pasvolsky O , Heiman L, Popovtzer A, Zimra Y, Rabizadeh E, Barshack I, Mardoukh C, Raanani P, Rozovski U. Genomic analysis of metastatic rhabdomyosarcoma masquerading as acute leukemia. Pathol Res Pract 216(1):152779, 2020. e-Pub 2019. PMID: 31813602.
33. Shargian-Alon L, Yahav D, Rozovski U, Dovrat S, Amitai I, Sela-Navon M, Pasvolsky O , Raanani P, Yeshurun M. Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience. Leuk Lymphoma 60(9):2230-2236, 2019. e-Pub 2019. PMID: 30773083.
34. Pasvolsky O , Morelli O, Rozovski U, Vaturi M, Wolach O, Amitai I, Vaxman I, Ratzon R, Yeshurun M, Kornowski R, Iakobishvilli Z, Raanani P. Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk 19(7):e343-e348, 2019. e-Pub 2019. PMID: 30948329.
35. Pasvolsky O , Zoref-Lorenz A, Abadi U, Geiger KR, Hayman L, Vaxman I, Raanani P, Leader A. Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series. Int J Hematol 109(5):553-562, 2019. e-Pub 2019. PMID: 30850926.
36. Gover-Proaktor A, Granot G, Pasmanik-Chor M, Pasvolsky O , Shapira S, Raz O, Raanani P, Leader A. Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells. Leuk Lymphoma 60(1):189-199, 2019. e-Pub 2018. PMID: 29741440.
37. Pasvolsky O , Berger T, Bernstine H, Hayman L, Raanani P, Vidal L. Spontaneous Regression of Hodgkin Lymphoma: Case Report and Review of the Literature. Acta Haematol 141(1):14-18, 2019. e-Pub 2018. PMID: 30439716.
38. Pasvolsky O , Leader A. Postpartum Hemophagocytic Lymphohystiocytosis: A New Entity Is Born. Acta Haematol 141(1):61-62, 2019. e-Pub 2018. PMID: 30537710.
39. Castillo JJ, Itchaki G, Paludo J, Varettoni M, Buske C, Eyre TA, Chavez JC, Shain KH, Issa S, Palomba ML, Pasvolsky O , Simpson D, Talaulikar D, Tam CS, Tedeschi A, Ansell SM, Nayak L, Treon SP. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study. Blood 133(4):299-305, 2019. e-Pub 2018. PMID: 30523119.
40. Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O , Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study. Clin Microbiol Infect 24(7):749-754, 2018. e-Pub 2017. PMID: 29208561.
41. Grisariu S, Vaxman I, Gatt M, Elias S, Avni B, Arad A, Pasvolsky O, Raanani P, Paltiel O. Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature. Hematol Oncol 35(4):591-598, 2017. e-Pub 2016. PMID: 27734521.
42. Shargian-Alon L, Pasvolsky O , Raanani P. Thalassemia Major and Intermedia in Patients Older than 35 Years: A Single Center Experience. Isr Med Assoc J 19(12):767-771, 2017. PMID: 29235740.
43. Gover-Proaktor A, Granot G, Shapira S, Raz O, Pasvolsky O , Nagler A, Lev DL, Inbal A, Lubin I, Raanani P, Leader A. Ponatinib reduces viability, migration, and functionality of human endothelial cells. Leuk Lymphoma 58(6):1455-1467, 2017. e-Pub 2016. PMID: 27733071.
44. Shashar M, Chernichovski T, Pasvolsky O , Levi S, Grupper A, Hershkovitz R, Weinstein T, Schwartz IF. Vascular Endothelial Growth Factor Augments Arginine Transport and Nitric Oxide Generation via a KDR Receptor Signaling Pathway. Kidney Blood Press Res 42(2):201-208, 2017. e-Pub 2017. PMID: 28478454.
45. Pasvolsky O , Leader A, Iakobishvili Z, Wasserstrum Y, Kornowski R, Raanani P. Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardiooncology 1(1):5, 2015. e-Pub 2015. PMID: 33530148.
46. Wasserstrum Y, Kornowski R, Raanani P, Leader A, Pasvolsky O , Iakobishvili Z. Hypertension in cancer patients treated with anti-angiogenic based regimens. Cardiooncology 1(1):6, 2015. e-Pub 2015. PMID: 33530150.
47. Perl L, Pasvolsky O , Lifshitz L, Mekori YA, Hershko AY. Increased eosinophilic responses in splenectomized patients. Ann Allergy Asthma Immunol 108(1):34-38, 2012. e-Pub 2011. PMID: 22192963.
48. Goldin Y, Pasvolsky O , Rogowski O, Shapira I, Steinvil A, Halpern P, Serov J, Deutsch V, Aviram G, Berliner S. The diagnostic yield of D-Dimer in relation to time from symptom onset in patients evaluated for venous thromboembolism in the emergency medicine department. J Thromb Thrombolysis 31(1):1-5, 2011. PMID: 20419335.

Book Chapters

1. Gutierrez C, Pasvolsky O , Kebriaei P. CAR T-Cell Therapy and Critical Care Considerations. In: Pulmonary and Critical Care Considerations of Hematopoietic. Springer, Cham, 427-435, 2023.
2. Pasvolsky O , Ulmansky R, Naparstek Y and Hershko AY. Anti-collagen antibodies. In: Autoantibodies. 3rd. Elsevier: Amsterdam, The Netherlands, 717-722, 2014.